Korea

Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

- Employing Lunit INSIGHT MMG, a Turkish study showcases 70% efficiency improvements, advancements in early cancer detection, and interval cancer detection in mammography SEOUL, South Korea, April 8, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cance...

2024-04-08 21:00 1292

Medit Unveils i900: The Next Evolution of Intraoral Scanners

Secure a front-row seat for the debut of Medit i900 and discover the latest cutting-edge dental technology SEOUL, South Korea and LONG BEACH, Calif., April 8, 2024 /PRNewswire/ -- Medit (www.medit.com ), a leading provider of dental 3D scanners and digital dentistry solut...

2024-04-08 21:00 925

Rainbow Robotics unveils RB-Y1, Korea's first bimanual mobile manipulator

- In March, "2024 Smart Factory Automation Industry Exhibition (SF+AW 2024)" was first released to the public - Posting various performance videos of bimanual mobile manipulator in the form of humanoids on YouTube channels DAEJEON, South Korea, April 4, 2024 /PRNewswire/ -- Rainbow Robotics

2024-04-05 09:30 2196

LG Energy Solution's $5.5 Billion Stand-Alone Battery Manufacturing Complex Project in Arizona Well Underway

* LG Energy Solution invites Arizona state government and local community officials for a construction progress update on its second U.S. stand-alone facility * Completion and start of production expected in about two years, with full-scale hiring for thousands of new jobs to begin in the sec...

2024-04-04 06:30 1577

SK hynix Signs Investment Agreement of Advanced Chip Packaging with Indiana

* To build advanced packaging facility for next-generation HBM, while collaborating withPurdue University for R&D * Selects Indiana for strong support provided by the state and local government, infrastructure for manufacturing, and talent atPurdue. * Industry's first investment in advanced ...

2024-04-04 02:50 1272

RSN Recognized Among Top 500 High-Growth Companies in Asia-Pacific by Financial Times

SEOUL, South Korea, April 3, 2024 /PRNewswire/ -- RSN , a leading player in AI-driven big data analytics, has secured a prestigious spot in the coveted"2024 Asia-Pacific High Growth Company" list , announced by...

2024-04-03 20:00 1086

GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

YONGIN, South Korea, April 2, 2024 /PRNewswire/ -- GC Cell , a fully integrated cell therapy pioneer has announced poster presentations from studies of its preclinical study of GL205 (GCC2005), a CD5 CAR-NK targeting malignant T-cell lymphoma, and real-world data f...

2024-04-02 23:00 1737

Hyundai Motor's 'Dogbility' Campaign Fetches Laughs and Sparks Conversations About Universal Mobility

* Hyundai's 'Dogbility' concept highlights innovative features for imagined canine mobility and underscores Hyundai Motor's vision of universal mobility for everyone * The April Fools' Day campaign uses generative AI to produce creative visuals like canine-ergonomic rotary steering wheels and...

2024-04-02 09:30 1156

/DISREGARD RELEASE: Nuvilab/

We are advised by Nuvilab that journalists and other readers should disregard the news release, Nuvilab Delivers Keynote Speech at Aramark Innova Summit in Chile, issued 01-Apr-2024 over PR Newswire. ...

2024-04-02 01:32 1963

Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

- Lunit's AACR 2024 presentations to spotlight HER2 mutation insights and CNTN4's role in immunotherapy success, pioneering next-gen personalized treatment approaches, supported by the AI-powered Lunit SCOPE suite SEOUL, South Korea, April 1, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading...

2024-04-01 21:00 1520

d'Alba's Vegan Beauty Revolution: White Truffle Spray Serum Takes Global Market by Storm

SEOUL, South Korea, April 1, 2024 /PRNewswire/ -- Renowned for its iconic White Truffle First Spray Serum, premium vegan brand d'Alba is experiencing remarkable growth in the international market, and there seems to be no slowing down.

2024-04-01 20:00 1498

SKT Expands A.'s Call Features to All Subscribers

SEOUL, South Korea, March 31, 2024 /PRNewswire/ -- SK Telecom (NYSE:SKM, "SKT") today announced that it has upgraded call-related features of its personalized  AI personal assistant, "A." (pronounced "A dot"), and made features such as "A. Call Translator" available for Android device users. By ...

2024-04-01 10:07 1293

Prinics launches a new 'KODAK ERA' product line up

SEOUL, South Korea, March 30, 2024 /PRNewswire/ -- Prinics, a Korean-based printing technology company specializing in photo printers, launched its 'ERA' line with 6 products - Kodak MiniShot 4 ERA, Kodak MiniShot 3 ERA, Kodak MiniShot 2 ERA, Kodak Mini 3 ERA, Kodak Mini 2 ERA, and Kodak Dock ERA...

2024-03-30 22:00 1783

DeepBrain AI with Estonian Ministry of Economy, Information and Communication discusses introduction of AI human Public Service

*  A delegation from Estonia, including Minister Tit Lysalo and Ambassador to Korea Sten Schwede, visited DeepBrain AI headquarters. * Introduce AI human solutions and discuss cooperation plans to implement a virtual assistant at the Estonian Information System Agency PALO ALTO, Calif., March...

2024-03-30 04:51 2509

LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC)

* Phase 2 study is underway and LB-P8 is the only live biotherapeutic product currently reported to be in clinical development for the treatment of PSC * FDA's Fast Track designation for LB-P8 underlines the urgent need for treatment options to fulfill the unmet medical needs of people affecte...

2024-03-29 21:00 2326

Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade

SEONGNAM, South Korea and ATLANTA, March 28, 2024 /PRNewswire/ --  Bridge Biotherapeutics (KQ288330) , a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr.Jessica M...

2024-03-29 06:00 3736

Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology

SEONGNAM, South Korea and AURORA, Colo., March 26, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330) , a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr.Raul...

2024-03-27 06:00 378

EIPGRID Acquires FE and Ventures into 'VPP+EaaS' Business

* EIPGRID, a renowned global provider of community energy solutions, embarks on a groundbreaking initiative by launching its own community energy service in Jeju Island, Korea. * This marks the first step and a significant leap towards establishing the innovative 'VPP+EaaS' business ecosystem...

2024-03-27 00:00 313

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

- New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO's analysis of tumor microenvironment SEOUL, South Korea, March 26, 2024 /PRNewswire/ -- Lunit (K...

2024-03-26 21:00 717

TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients

* TU7710 has the potential to be a highly effective and long-acting treatment for bleeding episodes as well as for preventing bleeding during surgery or invasive procedures in hemophilia patients with inhibitors * Interim results from an ongoing Phase 1a study in healthy male volunteers will ...

2024-03-26 20:00 695
12345 ... 99